3Hagemeister F. Rituximab for the treatment of non-hodgkin's lymphoma and chronie lymphoeytic leukaemia[ J ]. Drugs,2010 ;70 ( 3 ) :261-72.
4Morton LM, Gurtis RE, Linet MS, et al. Second malignancy risks after non- Hodgkin's lymphoma and chronic lymphocytic leukemia differences by lymphoma subtype[J]. J Glin Onco1,2010 ;28 (33) :4935-44.
5Nicholson ML, Kaushik M, Lewis GR, et al. Randomized clinical trial of laparospic versus open donor nephrectomy[J] Br J Surg, 2010;97 ( I ) : 21-8.
7Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunc- tion and infections in patients with cirrhosis[J]. Clin Gastroc- nterol Hepatol,2011,9(1) :727-738.
8Kusano T, Inomata M, Hiratsuka T, et al. A comparison of laparoscopic and open surgery following pre-operative chemora- diation therapy for locally advanced lower rectal cancer[J]. Jpn J Clin Oncol,2014,44(4) :305-310.
9MariKPE,Flemmer M. Immunonutrition in the surgical patient [J], Minerva Anestesiol,2012,78(2) :336-342.
10Vukasin P, Orkga AE, Greme FL, et al. Wound recurrence following laparoscopic colon cancer resection:results of the American society of Colon and Rectal Surgeons Laparoscop- ic Registry [ J ~. Dis Colon Rectum, 1996,39 ( suppl 10) : s20-23.